Immunosuppressive effects of leflunomide in experimental chronic vascular rejection

Transplantation

Volumn 60, Issue 8, 1995, Pages 887-890

  Swan, Suzanne K ^a,b   Crary, Gretchen S ^b   Guijarro, Carlos ^b   O’Donnell, Michael P ^b   Keane, William F ^b   Kasiske, Bertram L ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 6; LEFLUNOMIDE; LEUKOTRIENE B4;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GRAFT REJECTION; HUMAN; HUMAN CELL; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; AORTA; CELL DIVISION; CELLS, CULTURED; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-6; ISOXAZOLES; LEUKOCYTES, MONONUCLEAR; LEUKOTRIENE B4; RATS;

EID: 0028856439     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199510000-00025     Document Type: Article

References (13)

1. Foster MC. Wenham PW, Rowe PA, et al. The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Engl 1989; 71: 44.
2. Xiao F. Chong AS, Foster P, et al. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation 1994; 58: 828.
3. McChesney LP, Xiao F, Sankary HN, et al. An evaluation of leflunomide in the canine renal transplantation model. Transplantation 1994; 57: 1717.
4. Mrowka C, Thoenes GH, Langer KH, Bartlett RR. Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide. Ann Hematol 1994; 68: 195.
5. Loppnow H, Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 1990; 85: 731.
6. Rola-Pleszczvnski M, Stankova J. Leukotriene B, enhances in-terleukin-6 production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and post transcriptional mechanisms. Blood 1992; 80: 1004.
7. Henderson WR, Jr. The role of leukotrienes in inflammation. Ann Intern Med 1994; 121: 684.
8. Atluru D, Polam S, Atluru S, Woloschak GE. Regulation of mitogen-stimulated human T-cell proliferation, 1L-2 production, and IL-2 receptor expression by protein kinase C inhibition. Cell Immunol 1990; 129: 310.
9. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156.
10. Hirano T, Yasukara K, Harada H, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lympho cytes to produce immunoglobulin. Nature 1986; 324: 73.
11. Iruela-Arispe ML, Diglio CA, Sage EH. Modulation of extracel lular matrix proteins by endothelial cells undergoing angiogen-esis in vitro. Arterioscler Thromb 1991; 11: 805.
12. Weibel ER: Stereological methods: practical methods for biolog ical morphology, vol 1. London, Academic, 1979: 1.
13. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Häyry P. Chronic rejection in rat aortic allografts-an experimental model for transplant arteriosclerosis. Arterioscler Thromb 1991; 11: 671.